Literature DB >> 23621195

Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand.

Sudarat Sriputtha1, Narong Khuntikeo, Supannee Promthet, Supot Kamsa-Ard.   

Abstract

Intrahepatic cholangiocarcinoma (ICC), one of the primary liver cancers, is frequent in the northeastern part of Thailand. Surgical resection remains the best method of treatment, but patients suffering from ICC usually present at a late stage of the disease. Studies of survival and prognostic factors after surgery remain rare. The aim here was to evaluate the survival rate and factors affecting the survival of patients with intrahepatic cholangiocarcinoma after surgery. The study used a retrospective cohort design. The subjects were 73 consecutive patients with ICC, who were admitted for surgery to Srinagarind Hospital, Khon Kaen University, during the period 2005-2009. The censoring date was 31 December, 2011, data being evaluated using uni- and multivariate analyses. Postoperative survival analysis was performed by the Kaplan-Meier method, and the Cox proportional hazard model was used to identify independent prognostic factors. The total follow-up time was 99 person-years. The total number of deaths was 59, giving a mortality rate of 59 per 100 person-years. The cumulative 1-, 3-, and 5-year survival rates were 52.1%, 21.7%, and 11.2%, respectively. The median duration of survival after resection was 12.4 months. Univariate analysis revealed stage of disease, lymph node metastasis, histological type, histological grade and macroscopic classification to be statistically significant (p-value<0.05) prognostic factors. In the multivariate analysis, only macroscopic classification was statistically significant (p-value<0.05). In conclusion, macroscopic classification was the only independent factor found to be significantly associated with survival following surgical treatment of ICC.

Entities:  

Mesh:

Year:  2013        PMID: 23621195     DOI: 10.7314/apjcp.2013.14.2.1107

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  15 in total

1.  Blocking of the EGFR-STAT3 signaling pathway through afatinib treatment inhibited the intrahepatic cholangiocarcinoma.

Authors:  Changhe Zhang; Hong Xu; Zhenping Zhou; Ye Tian; Xiaofei Cao; Guochang Cheng; Qinghong Liu
Journal:  Exp Ther Med       Date:  2018-04-05       Impact factor: 2.447

2.  Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells.

Authors:  Tin May Aung; Atit Silsirivanit; Apinya Jusakul; Waraporn Chan-On; Tanakorn Proungvitaya; Sittiruk Roytrakul; Siriporn Proungvitaya
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

3.  Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases.

Authors:  Marut Laohaviroj; Yaovalux Chamgramol; Chawalit Pairojkul; Jason Mulvenna; Banchob Sripa
Journal:  Asian Pac J Cancer Prev       Date:  2016

4.  Cohort profile: cholangiocarcinoma screening and care program (CASCAP).

Authors:  Narong Khuntikeo; Nittaya Chamadol; Puangrat Yongvanit; Watcharin Loilome; Nisana Namwat; Paiboon Sithithaworn; Ross H Andrews; Trevor N Petney; Supannee Promthet; Kavin Thinkhamrop; Chaiwat Tawarungruang; Bandit Thinkhamrop
Journal:  BMC Cancer       Date:  2015-06-09       Impact factor: 4.430

5.  Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis.

Authors:  Chanitra Thuwajit; Peti Thuwajit; Pranisa Jamjantra; Chawalit Pairojkul; Sopit Wongkham; Vajarabhongsa Bhudhisawasdi; Junya Ono; Shoichiro Ohta; Kiminori Fujimoto; Kenji Izuhara
Journal:  Oncol Lett       Date:  2017-05-25       Impact factor: 2.967

6.  Role of cantharidin in the activation of IKKα/IκBα/NF‑κB pathway by inhibiting PP2A activity in cholangiocarcinoma cell lines.

Authors:  Huijiang Zhou; Jiangfeng Xu; Shuai Wang; Jinfeng Peng
Journal:  Mol Med Rep       Date:  2018-04-05       Impact factor: 2.952

7.  Evaluating a preoperative protocol that includes magnetic resonance imaging for lymph node metastasis in the Cholangiocarcinoma Screening and Care Program (CASCAP) in Thailand.

Authors:  Metha Songthamwat; Nittaya Chamadol; Narong Khuntikeo; Jadsada Thinkhamrop; Supinda Koonmee; Nathaphop Chaichaya; Jeffrey Bethony; Bandit Thinkhamrop
Journal:  World J Surg Oncol       Date:  2017-09-20       Impact factor: 2.754

Review 8.  Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms.

Authors:  Sukanya Roy; Shannon Glaser; Sanjukta Chakraborty
Journal:  Front Med (Lausanne)       Date:  2019-12-18

9.  Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinoma.

Authors:  Rucksak Rucksaken; Chawalit Pairojkul; Porntip Pinlaor; Narong Khuntikeo; Sittiruk Roytrakul; Carlo Selmi; Somchai Pinlaor
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

10.  A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand.

Authors:  Narong Khuntikeo; Watcharin Loilome; Bandit Thinkhamrop; Nittaya Chamadol; Puangrat Yongvanit
Journal:  PLoS Negl Trop Dis       Date:  2016-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.